Viktor Roschke
Fondateur chez Neuraly, Inc.
Fortune : 2 M $ au 31/05/2024
Postes actifs de Viktor Roschke
Sociétés | Poste | Début | Fin |
---|---|---|---|
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Directeur/Membre du Conseil | - | - |
Secrétaire Général | - | - | |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Neuraly, Inc. provides healthcare services. The company was founded by Seulki Lee and Viktor Roschke in 2016 and is headquartered in Gaithersburg, MD. | Directeur/Membre du Conseil | 01/01/2016 | - |
Directeur Technique/Scientifique/R&D | 01/01/2016 | - | |
Fondateur | 01/01/2016 | - | |
D&D Pharma Tech Co., Ltd.
D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology D&D Pharma Tech Co., Ltd. engages in drug research and development. It develops medicines for metabolic, degenerative brain, and fibrotic diseases. The company was founded by Seul-Ki Lee, Seong-Mook Im and Kang Choon Lee on November 28, 2014 and is headquartered in Suwon, South Korea. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Viktor Roschke
Anciens postes connus de Viktor Roschke
Sociétés | Poste | Début | Fin |
---|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2005 | 01/01/2005 |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Directeur des opérations | - | - |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Directeur Technique/Scientifique/R&D | 05/07/2012 | - |
Corporate Officer/Principal | 10/09/2010 | - |
Formation de Viktor Roschke
Novosibirsk State University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
2 | |
Corée du Sud | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 5 |
Retail Trade | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
Health Technology |
Entreprise privées | 5 |
---|---|
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Retail Trade |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Neuraly, Inc. provides healthcare services. The company was founded by Seulki Lee and Viktor Roschke in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Bourse
- Insiders
- Viktor Roschke
- Expérience